To require the Food and Drug Administration to expedite review of pharmaceuticals that are approved for marketing in the European Union.
The bill’s titles are written by its sponsor.
Jun 19, 2014
113th Congress, 2013–2015
Died in a previous Congress
This bill was introduced on June 19, 2014, in a previous session of Congress, but was not enacted.
Representative for Ohio's 15th congressional district
Read Text »
Last Updated: Jun 19, 2014
Length: 2 pages
This is the first step in the legislative process.
Reintroduced Bill — Introduced
This activity took place on a related bill, H.R. 1455.
H.R. 4918 (113th) was a bill in the United States Congress.
A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
This bill was introduced in the 113th Congress, which met from Jan 3, 2013 to Jan 2, 2015. Legislation not enacted by the end of a Congress is cleared from the books.
How to cite this information.
We recommend the following MLA-formatted citation when using the information you see here in academic work:
Civic Impulse. (2016). H.R. 4918 — 113th Congress: Speeding Access to Already Approved Pharmaceuticals Act of 2014. Retrieved from https://www.govtrack.us/congress/bills/113/hr4918
“H.R. 4918 — 113th Congress: Speeding Access to Already Approved Pharmaceuticals Act of 2014.” www.GovTrack.us. 2014. October 21, 2016 <https://www.govtrack.us/congress/bills/113/hr4918>
|title=H.R. 4918 (113th)
|accessdate=October 21, 2016
|author=113th Congress (2014)
|date=June 19, 2014
|quote=Speeding Access to Already Approved Pharmaceuticals Act of 2014
Where is this information from?
GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.